Follistim is a drug owned by Organon Usa Inc. It is protected by 1 US drug patent filed in 2013 out of which all have expired. Based on its patents and exclusivities, its generic launch date is estimated to be Jun 16, 2015. Details of Follistim's patents and their expiration are given in the table below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| These drug patents focus on the other aspects of the drug like dosage, mode of administration (oral, tablet, capsules, liquids etc). | |||
| US5767251 | Recombinant heterodimeric human fertility hormones, and methods, cells, and vectors and DNA for the production thereof |
Jun, 2015
(9 years ago) |
Expired
|
US patents provide insights into the exclusivity only within the United States, but Follistim is protected by patents in multiple countries. Understanding the full scope of patent protection is crucial in strategizing market entry. By looking at the broader patent landscape, you can identify markets with weaker patent protection which could be ideal generic entry points. The following section offers details on Follistim's family patents as well as insights into ongoing legal events on those patents.
Follistim's Family Patents
Explore Our Curated Drug Screens
Generic Launch
Generic Release Date:
Follistim's generic launch date based on the expiry of its last outstanding patent is estimated to be Jun 16, 2015 (This date is subject to change depending upon the patent filing activities by the drug owner or exclusivity additions to its drug application)
Follistim Generics:
There are no approved generic versions for Follistim as of now.
Alternative Brands for Follistim
There are several other brand drugs using the same active ingredient (Follitropin Alfa/beta) as Follistim. Given below is the list of those companies and their brand drugs, to help you identify new opportunities, assess competitors, and plan your market strategies more effectively.
| Drug Owner | Drug Name | |||
|---|---|---|---|---|
| Emd Serono |
| |||
| Organon Usa Inc |
|
About Follistim
Follistim is a drug owned by Organon Usa Inc. Follistim uses Follitropin Alfa/Beta as an active ingredient. Follistim was launched by Organon Usa Inc in 1997.
Approval Date:
Follistim was approved by FDA for market use on 29 September, 1997.
Active Ingredient:
Follistim uses Follitropin Alfa/beta as the active ingredient. Check out other Drugs and Companies using Follitropin Alfa/beta ingredient
Dosage:
Follistim is available in injectable form for im-sc use. Given below is detailed information on Dosage -
| Strength | Dosage Form | Availability | Application Pathway |
|---|---|---|---|
| 75 IU/VIAL | INJECTABLE | Discontinued | IM-SC |
| 150 IU/VIAL | INJECTABLE | Discontinued | IM-SC |